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Background
Atrial natriuretic peptide (ANP), via its guanylyl cyclase A
(GC-A) receptor and cyclic GMP formation, exerts cardiac
antihypertrophic and antifibrotic actions. Conversely,
aldosterone promotes pathological cardiac remodeling via
the mineralocorticoid receptor (MR). To investigate
whether local cardiac ANP/GC-A signaling counteracts
the effects of aldosterone during experimental hyperten-
sive cardiac remodeling.
Results
We studied the impact of the MR antagonist eplerenone
(100 mg/kg/day) on cardiac remodeling after transverse
aortic constriction (TAC) in mice with conditional, cardi-
omyocyte-restricted deletion of GC-A (CM GC-A KO)
[1] or cGMP-dependent protein kinase I (CM cGK I KO)
[2] and respective controls (n=10 in each group). Left
ventricular (LV) hypertrophy and interstitial fibrosis were
significantly exacerbated in both CM GC-A KO and cGK
I KO mice after TAC. These histological changes were
accompanied by decreased LV SERCA2a expression,
increased CTGF and LV dilatation together with contrac-
tile dysfunction. Eplerenone had no effect on systemic
blood pressure but fully prevented these pressure-over-
load induced cardiac morphological, molecular and func-
tional alterations in both CM GC-A KO and CM cGK I
KO mice. However, eplerenone did not inhibit TAC-
induced MAPK ERK1/2 phosphorylation/activation, sug-
gesting that the non-genomic effects of aldosterone are
not involved in exacerbated hypertensive cardiac remo-
deling of the KO mice. Intriguingly, in transfected HEK
293 cells, ANP inhibited the aldosterone-induced nuclear
translocation of the MR.
Conclusion
ANP, via GC-A/cGMP/cGKI signaling in cardiac myocytes,
attenuates hypertensive cardiac remodeling and dysfunc-
tion. These protective ANP effects seem to be mediated at
least in part by counterregulation of the deleterious geno-
mic (MR-mediated) cardiac actions of aldosterone.
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